Uptake of cobalamin and markers of cobalamin status: A longitudinal study of healthy pregnant women

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 11, 2011, Pages 1877-1882

  Greibea, Eva ^a   Andreasena, Birgitte Horst ^a   Lildballe, Dorte L ^a   Morkbak, Anne L ^a   Hvas, Anne Mette ^a   Nexo, Ebba ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Absorption; Cobalamin; Haptocorrin; Holotranscobalamin; Pregnancy; Vitamin B12

Indexed keywords

COBALAMIN; COBALAMIN DERIVATIVE; CYANOCOBALAMIN; HAPTOCORRIN; HOLOTRANSCOBALAMIN; HOMOCYSTEINE; METHYLMALONIC ACID; TRANSCOBALAMIN; UNCLASSIFIED DRUG;

ABSORPTION; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GESTATION PERIOD; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; VITAMIN METABOLISM;

ADULT; BIOLOGICAL MARKERS; DENMARK; FEMALE; HOMOCYSTEINE; HUMANS; LONGITUDINAL STUDIES; METHYLMALONIC ACID; PREGNANCY; PREGNANCY TRIMESTERS; TRANSCOBALAMINS; VITAMIN B 12;

EID: 80755171195     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.682     Document Type: Article

References (21)

1. Carmel R, Green R, Rosenblatt DS, Watkins D. Update on cobalamin, folate, and homocysteine. Hematology Am Soc Hematol Educ Program 2003;62-81.
2. Groenen PM, van Rooij AI, Peer PG, Gooskens RH, Zielhuis GA, Steegers-Theunissen RP. Marginal maternal vitamin B12 status increases the risk of offspring with spina bifida. Am J Obstet Gynecol 2004;191:11-7. (Pubitemid 39077950)
3. Afman LA, Van Der Put NM, Thomas CM, Trijbels JM, Blom HJ. Reduced vitamin B12 binding by transcobalamin II increases the risk of neural tube defects. QJM 2001;94:159-66. (Pubitemid 32242004)
4. Shojania AM. Folic acid and vitamin B12 deficiency in pregnancy and in the neonatal period. Clin Perinatol 1984;11:433- 59.
5. Koebnick C, Heins UA, Dagnelie PC, Wickramasinghe SN, Ratnayaka ID, Hothorn T, et al. Longitudinal concentration of vitamin B(12) and vitamin B(12)-binding proteins during uncomplicated pregnancy. Clin Chem 2002;48:928-33. (Pubitemid 34587594)
6. Morkbak AL, Hvas AM, Milman N, Nexo E. Holotranscobalamin remains unchanged during pregnancy. Longitudinal changes of cobalamin and their binding proteins during pregnancy and postpartum. Haematologica 2007;92:1711-2.
7. Schilling RF. Intrinsic factor studies II. The effect of gastric juice on the urinary escretion of radioactivity after the oral administration of radioactive vitamin B12. J Lab Clin Med 1953;42: 860-6.
8. Bor MV, Nexo E, Hvas AM. Holo-transcobalamin concentration and transcobalamin saturation reflect recent vitamin B12 absorption better than does serum vitamin B12. Clin Chem 2004;50: 1043-9. (Pubitemid 38725792)
9. Bor MV, Cetin M, Aytac S, Altay C, Nexo E. Nonradioactive vitamin B12 absorption test evaluated in controls and in patients with inherited malabsorption of vitamin B12. Clin Chem 2005;51:2151-5. (Pubitemid 41532633)
10. Hvas AM, Morkbak AL, Nexo E. Plasma holotranscobalamin compared with plasma cobalamins for assessment of vitamin B12 absorption; optimization of a non-radioactive vitamin B12 absorption test (CobaSorb). Clin Chem Acta 2007;376:150-4. (Pubitemid 44880994)
11. Hardlei TF, Morkbak AL, Bor MV, Bailey LB, Hvas AM, Nexo E. Assessment of vitamin B(12) absorption based on the accumulation of orally administered cyanocobalamin on transcobalamin. Clin Chem 2010;56:432-6.
12. Nexo E, Christensen AL, Petersen TE, Fedosov SN. Measurement of transcobalamin by ELISA. Clin Chem 2000;46:1643- 9.
13. Nexo E, Christensen AL, Hvas AM, Petersen TE, Fedosov SN. Quantification of holotranscobalamin, a marker of vitamin B12 deficiency. Clin Chem 2002;48:561-2. (Pubitemid 34174588)
14. Morkbak AL, Heimdal RM, Emmens K, Molloy A, Hvas AM, Schneede J, et al. Evaluation of the technical performance of novel holotranscobalamin (holoTC) assays in a multicenter European demonstration project. Clin Chem Lab Med 2005;43: 1058-64. (Pubitemid 41581961)
15. Morkbak AL, Pedersen JF, Nexo E. Glycosylation independent measurement of the cobalamin binding protein haptocorrin. Clin Chim Acta 2005;356:184-90. (Pubitemid 40779901)
16. Hardlei TF, Nexo E. A new principle for measurement of cobalamin and corrinoids, used for studies of cobalamin analogs on serum haptocorrin. Clin Chem 2009;55:1002-10.
17. Nexo E. Variation with age of reference values for P-cobalamins. Scand J Haematol 1983;30:430-2. (Pubitemid 13065537)
18. Rasmussen K, Moller J, Lyngbak M, Pedersen AM, Dybkjaer L. Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem 1996;42:630-6. (Pubitemid 26111884)
19. Rustad P, Felding P, Franzson L, Kairisto V, Lahti A, Mårtensson A, et al. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest 2004;64:271-84.
20. Milman N, Byg KE, Bergholt T, Eriksen L, Hvas AM. Cobalamin status during normal pregnancy and postpartum: a longitudinal study comprising 406 Danish women. Eur J Haematol 2006;76:521-5.
21. Milman N, Bergholt T, Byg KE, Eriksen L, Hvas AM. Reference intervals for haematological variables during normal pregnancy and postpartum in 434 healthy Danish women. Eur J Haematol 2007;79:39-46. (Pubitemid 47000621)